Global and Region Drug Modeling Softwares Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Drug Modeling Softwares market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Drug Modeling Softwaresmarket, defines the market attractiveness level of Drug Modeling Softwares market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Drug Modeling Softwares industry, describes the types of Drug Modeling Softwares market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drug Modeling Softwares market and the development prospects and opportunities of Drug Modeling Softwares industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drug Modeling Softwares market in Chapter 13.

    By Player:

    • Acellera

    • Nimbus Therapeutics

    • Dassault Systemes

    • Instem(Leadscope)

    • Genedata AG

    • Chemical Computing Group ULC

    • Schrodinger Inc

    • Compugen Ltd

    • Biognos AB

    • JSR Corporation(Crown Bioscience)

    By Type:

    • Database

    • Software

    • Others

    By End-User:

    • Drug Discovery and Development

    • Computational Physiological Medicine

    • Disease Modelling

    • Medical Imaging

    • Predictive Analysis of Drug Targets

    • Simulation Software

    • Cellular Simulation

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Drug Modeling Softwares Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Drug Modeling Softwares Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Drug Modeling Softwares Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Drug Modeling Softwares Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Drug Modeling Softwares Market Analysis and Outlook to 2022

    • 7.1 Global Drug Modeling Softwares Consumption (2017-2022)

    • 7.2 United States Drug Modeling Softwares Consumption (2017-2022)

    • 7.3 Europe Drug Modeling Softwares Consumption (2017-2022)

    • 7.4 China Drug Modeling Softwares Consumption (2017-2022)

    • 7.5 Japan Drug Modeling Softwares Consumption (2017-2022)

    • 7.6 India Drug Modeling Softwares Consumption (2017-2022)

    • 7.7 South Korea Drug Modeling Softwares Consumption (2017-2022)

    8 Region and Country-wise Drug Modeling Softwares Market Analysis and Outlook to 2028

    • 8.1 Global Drug Modeling Softwares Consumption Forecast (2022-2028)

    • 8.2 United States Drug Modeling Softwares Consumption Forecast (2022-2028)

    • 8.3 Europe Drug Modeling Softwares Consumption Forecast (2022-2028)

    • 8.4 China Drug Modeling Softwares Consumption Forecast (2022-2028)

    • 8.5 Japan Drug Modeling Softwares Consumption Forecast (2022-2028)

    • 8.6 India Drug Modeling Softwares Consumption Forecast (2022-2028)

    • 8.7 South Korea Drug Modeling Softwares Consumption Forecast (2022-2028)

    9 Global Drug Modeling Softwares Market Outlook by Types and Applications to 2022

    • 9.1 Global Drug Modeling Softwares Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Database Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Software Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Drug Modeling Softwares Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drug Discovery and Development Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Computational Physiological Medicine Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Disease Modelling Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Medical Imaging Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Predictive Analysis of Drug Targets Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Simulation Software Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Cellular Simulation Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Drug Modeling Softwares Market Outlook by Types and Applications to 2028

    • 10.1 Global Drug Modeling Softwares Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Database Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Software Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Drug Modeling Softwares Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Drug Discovery and Development Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Computational Physiological Medicine Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Disease Modelling Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Medical Imaging Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Predictive Analysis of Drug Targets Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Simulation Software Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.7 Global Cellular Simulation Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Drug Modeling Softwares Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Drug Modeling Softwares Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Drug Modeling Softwares Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Drug Modeling Softwares Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Drug Modeling Softwares Market Competitive Analysis

    • 14.1 Acellera

      • 14.1.1 Acellera Company Details

      • 14.1.2 Acellera Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Acellera Drug Modeling Softwares Product and Service

    • 14.2 Nimbus Therapeutics

      • 14.2.1 Nimbus Therapeutics Company Details

      • 14.2.2 Nimbus Therapeutics Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Nimbus Therapeutics Drug Modeling Softwares Product and Service

    • 14.3 Dassault Systemes

      • 14.3.1 Dassault Systemes Company Details

      • 14.3.2 Dassault Systemes Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Dassault Systemes Drug Modeling Softwares Product and Service

    • 14.4 Instem(Leadscope)

      • 14.4.1 Instem(Leadscope) Company Details

      • 14.4.2 Instem(Leadscope) Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Instem(Leadscope) Drug Modeling Softwares Product and Service

    • 14.5 Genedata AG

      • 14.5.1 Genedata AG Company Details

      • 14.5.2 Genedata AG Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Genedata AG Drug Modeling Softwares Product and Service

    • 14.6 Chemical Computing Group ULC

      • 14.6.1 Chemical Computing Group ULC Company Details

      • 14.6.2 Chemical Computing Group ULC Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Chemical Computing Group ULC Drug Modeling Softwares Product and Service

    • 14.7 Schrodinger Inc

      • 14.7.1 Schrodinger Inc Company Details

      • 14.7.2 Schrodinger Inc Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Schrodinger Inc Drug Modeling Softwares Product and Service

    • 14.8 Compugen Ltd

      • 14.8.1 Compugen Ltd Company Details

      • 14.8.2 Compugen Ltd Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Compugen Ltd Drug Modeling Softwares Product and Service

    • 14.9 Biognos AB

      • 14.9.1 Biognos AB Company Details

      • 14.9.2 Biognos AB Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Biognos AB Drug Modeling Softwares Product and Service

    • 14.10 JSR Corporation(Crown Bioscience)

      • 14.10.1 JSR Corporation(Crown Bioscience) Company Details

      • 14.10.2 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Drug Modeling Softwares

    • Figure Drug Modeling Softwares Picture

    • Table Global Drug Modeling Softwares Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Drug Modeling Softwares Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Drug Modeling Softwares Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Drug Modeling Softwares Consumption by Country (2017-2022)

    • Figure United States Drug Modeling Softwares Consumption and Growth Rate (2017-2022)

    • Table Europe Drug Modeling Softwares Consumption and Growth Rate (2017-2022)

    • Figure China Drug Modeling Softwares Consumption and Growth Rate (2017-2022)

    • Figure Japan Drug Modeling Softwares Consumption and Growth Rate (2017-2022)

    • Figure India Drug Modeling Softwares Consumption and Growth Rate (2017-2022)

    • Figure South Korea Drug Modeling Softwares Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Modeling Softwares Consumption Forecast by Country (2022-2028)

    • Figure United States Drug Modeling Softwares Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Drug Modeling Softwares Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Drug Modeling Softwares Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Drug Modeling Softwares Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Drug Modeling Softwares Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Drug Modeling Softwares Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Database Consumption and Growth Rate (2017-2022)

    • Figure Global Software Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Discovery and Development Consumption and Growth Rate (2017-2022)

    • Figure Global Computational Physiological Medicine Consumption and Growth Rate (2017-2022)

    • Figure Global Disease Modelling Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Imaging Consumption and Growth Rate (2017-2022)

    • Figure Global Predictive Analysis of Drug Targets Consumption and Growth Rate (2017-2022)

    • Figure Global Simulation Software Consumption and Growth Rate (2017-2022)

    • Figure Global Cellular Simulation Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Database Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Software Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Discovery and Development Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Computational Physiological Medicine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Disease Modelling Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Imaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Predictive Analysis of Drug Targets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Simulation Software Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cellular Simulation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Drug Modeling Softwares Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Drug Modeling Softwares Export by Region (Top 5 Countries) (2017-2028)

    • Table Acellera (Foundation Year, Company Profile and etc.)

    • Table Acellera Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acellera Drug Modeling Softwares Product and Service

    • Table Nimbus Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Nimbus Therapeutics Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nimbus Therapeutics Drug Modeling Softwares Product and Service

    • Table Dassault Systemes (Foundation Year, Company Profile and etc.)

    • Table Dassault Systemes Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dassault Systemes Drug Modeling Softwares Product and Service

    • Table Instem(Leadscope) (Foundation Year, Company Profile and etc.)

    • Table Instem(Leadscope) Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Instem(Leadscope) Drug Modeling Softwares Product and Service

    • Table Genedata AG (Foundation Year, Company Profile and etc.)

    • Table Genedata AG Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genedata AG Drug Modeling Softwares Product and Service

    • Table Chemical Computing Group ULC (Foundation Year, Company Profile and etc.)

    • Table Chemical Computing Group ULC Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chemical Computing Group ULC Drug Modeling Softwares Product and Service

    • Table Schrodinger Inc (Foundation Year, Company Profile and etc.)

    • Table Schrodinger Inc Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Schrodinger Inc Drug Modeling Softwares Product and Service

    • Table Compugen Ltd (Foundation Year, Company Profile and etc.)

    • Table Compugen Ltd Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Compugen Ltd Drug Modeling Softwares Product and Service

    • Table Biognos AB (Foundation Year, Company Profile and etc.)

    • Table Biognos AB Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biognos AB Drug Modeling Softwares Product and Service

    • Table JSR Corporation(Crown Bioscience) (Foundation Year, Company Profile and etc.)

    • Table JSR Corporation(Crown Bioscience) Drug Modeling Softwares Sales, Price, Value and Gross Profit (2017-2022)

    • Table JSR Corporation(Crown Bioscience) Drug Modeling Softwares Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.